Distribution of Smooth Muscle In Dartos In The Non Conspicuous Penis

NCT ID: NCT03295175

Last Updated: 2024-03-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2017-09-21

Study Completion Date

2024-03-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Non-conspicuous penis (congenital megaprepuce, occult penis) is a symptomatic malformation that includes phimosis and excessively baggy, urine-filled prepuce with alteration of the appearance of the penis. A redundant and enlarged foreskin is the main feature of this entity.This congenital anomaly is difficult to diagnose and may have association with other pathologies such as buried penis.

Currently, part of the megaprepuce skin is used to correct the defect. A recent study shows that patients with this pathology and hypospadias present mostly defects in the muscle dartos. The investigators do not know the physiological bases of the megaprepuce, neither the clinical and aesthetics implications of this abnormal tissue for the patient, and how this affects the postoperative evolution. With the present study the investigators intended to answer these questions and to open paths for future research in this area.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After informed consent, patients will be labeled with a research record number other than the identity document or the number of the attention. The urologist who perform the correction of the megaprepuce, will take a segment of the dartos and send it for histopathological analysis: staining with hematoxylin-eosin, smooth muscle actin marker, associated with the research record number. Same procedure will be performed with the controls and hypospadias group. Only the principal investigator will know the assignment of medical record and their respective group (congenital megaprepuce, hypospadias or controls). The samples will be sent to pathology without any clinical data, and they will be analyzed by two pathologists, both blind.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Congenital Urogenital Anomaly

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Congenital Megaprepuce

Congenital Megaprepuce Hematoxylin-eosin and smooth muscle actin markers

Hematoxylin-eosin and smooth muscle actin markers

Intervention Type DIAGNOSTIC_TEST

The foreskin arrives oriented in a single piece in formol to the unit of pathology, and in the pathology unit, they must:

1. Measure the length, width and thickness of the specimen. The specimen should include skin and mucosa with the underlying areolar tissue.
2. Examine the surfaces of the sample searching lesions, and describe them in size, appearance (warty, papillary, ulcerated), depth of invasion, and distance from the nearest cutting edge, if they are present.

Hypospadias

Hypospadias Hematoxylin-eosin and smooth muscle actin markers

Hematoxylin-eosin and smooth muscle actin markers

Intervention Type DIAGNOSTIC_TEST

The foreskin arrives oriented in a single piece in formol to the unit of pathology, and in the pathology unit, they must:

1. Measure the length, width and thickness of the specimen. The specimen should include skin and mucosa with the underlying areolar tissue.
2. Examine the surfaces of the sample searching lesions, and describe them in size, appearance (warty, papillary, ulcerated), depth of invasion, and distance from the nearest cutting edge, if they are present.

Control

Circumcision for non-medical reasons. Hematoxylin-eosin and smooth muscle actin markers

Hematoxylin-eosin and smooth muscle actin markers

Intervention Type DIAGNOSTIC_TEST

The foreskin arrives oriented in a single piece in formol to the unit of pathology, and in the pathology unit, they must:

1. Measure the length, width and thickness of the specimen. The specimen should include skin and mucosa with the underlying areolar tissue.
2. Examine the surfaces of the sample searching lesions, and describe them in size, appearance (warty, papillary, ulcerated), depth of invasion, and distance from the nearest cutting edge, if they are present.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hematoxylin-eosin and smooth muscle actin markers

The foreskin arrives oriented in a single piece in formol to the unit of pathology, and in the pathology unit, they must:

1. Measure the length, width and thickness of the specimen. The specimen should include skin and mucosa with the underlying areolar tissue.
2. Examine the surfaces of the sample searching lesions, and describe them in size, appearance (warty, papillary, ulcerated), depth of invasion, and distance from the nearest cutting edge, if they are present.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male patients scheduled for correction of congenital megaprepuce
* Male patients scheduled for correction of hypospadias
* Male patients scheduled for circumcision for non-medical reasons.

Exclusion Criteria

* Patients with a history of hypospadias correction.
Minimum Eligible Age

1 Month

Maximum Eligible Age

10 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital Universitario San Ignacio

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jose N Fernandez, MD

Role: PRINCIPAL_INVESTIGATOR

H

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Luis Gabriel Villarraga

Bogotá, , Colombia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Colombia

References

Explore related publications, articles, or registry entries linked to this study.

Ruiz E, Vagni R, Apostolo C, Moldes J, Rodriguez H, Ormaechea M, Giuseppucci C, de Badiola F, Bortagaray J, Perea C. Simplified surgical approach to congenital megaprepuce: fixing, unfurling and tailoring revisited. J Urol. 2011 Jun;185(6 Suppl):2487-90. doi: 10.1016/j.juro.2011.01.015. Epub 2011 Apr 27.

Reference Type RESULT
PMID: 21527191 (View on PubMed)

Summerton DJ, McNally J, Denny AJ, Malone PS. Congenital megaprepuce: an emerging condition--how to recognize and treat it. BJU Int. 2000 Sep;86(4):519-22. doi: 10.1046/j.1464-410x.2000.00509.x.

Reference Type RESULT
PMID: 10971284 (View on PubMed)

Rod J, Desmonts A, Petit T, Ravasse P. Congenital megaprepuce: a 12-year experience (52 cases) of this specific form of buried penis. J Pediatr Urol. 2013 Dec;9(6 Pt A):784-8. doi: 10.1016/j.jpurol.2012.10.010. Epub 2012 Oct 30.

Reference Type RESULT
PMID: 23116700 (View on PubMed)

Alexander A, Lorenzo AJ, Salle JL, Rode H. The Ventral V-plasty: a simple procedure for the reconstruction of a congenital megaprepuce. J Pediatr Surg. 2010 Aug;45(8):1741-7. doi: 10.1016/j.jpedsurg.2010.03.033.

Reference Type RESULT
PMID: 20713233 (View on PubMed)

Borsellino A, Spagnoli A, Vallasciani S, Martini L, Ferro F. Surgical approach to concealed penis: technical refinements and outcome. Urology. 2007 Jun;69(6):1195-8. doi: 10.1016/j.urology.2007.01.065.

Reference Type RESULT
PMID: 17572214 (View on PubMed)

Spinoit AF, Van Praet C, Groen LA, Van Laecke E, Praet M, Hoebeke P. Congenital penile pathology is associated with abnormal development of the dartos muscle: a prospective study of primary penile surgery at a tertiary referral center. J Urol. 2015 May;193(5):1620-4. doi: 10.1016/j.juro.2014.10.090. Epub 2014 Oct 23.

Reference Type RESULT
PMID: 25444989 (View on PubMed)

Cimador M, Catalano P, Ortolano R, Giuffre M. The inconspicuous penis in children. Nat Rev Urol. 2015 Apr;12(4):205-15. doi: 10.1038/nrurol.2015.49. Epub 2015 Apr 7.

Reference Type RESULT
PMID: 25850928 (View on PubMed)

Maizels M, Zaontz M, Donovan J, Bushnick PN, Firlit CF. Surgical correction of the buried penis: description of a classification system and a technique to correct the disorder. J Urol. 1986 Jul;136(1 Pt 2):268-71. doi: 10.1016/s0022-5347(17)44837-3.

Reference Type RESULT
PMID: 2873259 (View on PubMed)

Crawford BS. Buried penis. Br J Plast Surg. 1977 Jan;30(1):96-9. doi: 10.1016/s0007-1226(77)90046-7.

Reference Type RESULT
PMID: 836989 (View on PubMed)

Shenoy MU, Rance CH. Surgical correction of congenital megaprepuce. Pediatr Surg Int. 1999;15(8):593-4. doi: 10.1007/s003830050683.

Reference Type RESULT
PMID: 10631746 (View on PubMed)

Hadidi AT. Buried penis: classification surgical approach. J Pediatr Surg. 2014 Feb;49(2):374-9. doi: 10.1016/j.jpedsurg.2013.09.066. Epub 2013 Nov 7.

Reference Type RESULT
PMID: 24528990 (View on PubMed)

Baskin LS, Himes K, Colborn T. Hypospadias and endocrine disruption: is there a connection? Environ Health Perspect. 2001 Nov;109(11):1175-83. doi: 10.1289/ehp.011091175.

Reference Type RESULT
PMID: 11713004 (View on PubMed)

Baskin LS, Ebbers MB. Hypospadias: anatomy, etiology, and technique. J Pediatr Surg. 2006 Mar;41(3):463-72. doi: 10.1016/j.jpedsurg.2005.11.059.

Reference Type RESULT
PMID: 16516617 (View on PubMed)

Fernandez N, Lorenzo A, Bagli D, Zarante I. Altitude as a risk factor for the development of hypospadias. Geographical cluster distribution analysis in South America. J Pediatr Urol. 2016 Oct;12(5):307.e1-307.e5. doi: 10.1016/j.jpurol.2016.03.015. Epub 2016 Apr 22.

Reference Type RESULT
PMID: 27267992 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FM-CIE-0319-17

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Nordic Rectal Prolapse Study
NCT05569980 ENROLLING_BY_INVITATION